Skip to main content

Table 2 HRs (95% CIs) for risk of events in acute ischemic stroke patients with type-2 diabetes mellitus according to TyG index quartiles in this study

From: Predictive effect of triglyceride-glucose index on clinical events in patients with acute ischemic stroke and type 2 diabetes mellitus

 

Events, n (%)

Adjusted HR*

P value

Adjusted HR†

P value

Adjusted HR§

P value

1 year follow-up

Ischemic stroke recurrence

Quintile 1

74 (8.82)

Ref.

 

Ref.

 

Ref.

 

Quintile 2

69 (8.20)

0.98 (0.70, 1.36)

0.893

0.93 (0.66, 1.32)

0.698

1.01 (0.72, 1.43)

0.949

Quintile 3

95 (11.32)

1.38 (1.02, 1.88)

0.037

1.33 (0.92, 1.91)

0.127

1.41 (0.97, 2.03)

0.048

Quintile 4

67 (7.98)

1.05 (0.75, 1.48)

0.771

0.96 (0.55, 1.67)

0.886

1.06 (0.60, 1.85)

0.843

All-cause death

Quintile 1

63 (7.51)

Ref.

 

Ref.

 

Ref

 

Quintile 2

54 (6.42)

0.97 (0.67, 1.39)

0.861

1.01 (0.68, 1.51)

0.943

1.14 (0.76, 1.70)

0.531

Quintile 3

69 (8.22)

1.30 (0.92, 1.83)

0.138

1.62 (1.01, 2.61)

0.046

1.70 (1.06, 2.74)

0.028

Quintile 4

43 (5.12)

1.02 (0.69, 1.52)

0.924

1.61 (0.74, 3.52)

0.230

1.67 (0.76, 3.69)

0.201

Poor outcome

Quintile 1

201 (25.57)

Ref.

 

Ref.

 

Ref.

 

Quintile 2

193 (24.22)

1.05 (0.83, 1.33)

0.701

1.03 (0.78, 1.36)

0.849

1.07 (0.80, 1.43)

0.647

Quintile 3

205 (25.92)

1.16 (0.91, 1.47)

0.230

1.18 (0.85, 1.64)

0.313

1.24 (0.88, 1.75)

0.210

Quintile 4

155 (19.80)

0.99 (0.77, 1.27)

0.916

1.27 (0.77, 2.11)

0.348

1.38 (0.82, 2.33)

0.222

  1. Poor functional outcomes were defined as a modified Rankin Scale score of 3–6
  2. *Adjusted 1, for variables of age and sex
  3. †Adjusted 2, adjusted 1 + body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), NIHSS on admission, Glycosylated Hemoglobin, Type A1C (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein-C (LDL-C), fasting plasma glucose (FBG)
  4. §Adjusted 3, adjusted 2 + intravenous thrombolysis, medical history of ischemic stroke, intracranial hemorrhage (ICH), atrial fibrillation (AF), medication history of Statins, antidiabetics, antihypertension, medication at discharge of antidiabetic agents, statins, antihypertensive agents and TOAST subtypes